Neuronetics Moves to Acquire Greenbrook in Stock Deal
Company Announcements

Neuronetics Moves to Acquire Greenbrook in Stock Deal

Neuronetics ( (STIM) ) has issued an update.

Neuronetics, Inc. and Greenbrook TMS Inc. have announced an interim order for their proposed all-stock transaction arrangement, which, pending satisfaction of conditions, will see Neuronetics acquire all issued and outstanding Greenbrook shares. The arrangement will result in Neuronetics and Greenbrook shareholders owning approximately 57% and 43% of the combined company, respectively. Both companies’ boards have unanimously approved the deal, which is subject to shareholder votes at upcoming special meetings. This move is anticipated to create a leading entity in the Transcranial Magnetic Stimulation market, offering non-invasive treatments for mental health disorders.

See more data about STIM stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskNeuronetics Sees Q3 Revenue Rise Amid Strategic Acquisition
TheFlyNeuronetics sees Q4 revenue $19M-$20M, consensus $24.9M
TheFlyNeuronetics sees FY24 revenue $71M-$72M, consensus $77.92M
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App